Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8625 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8278 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8225 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8153 |
Intermediate Similarity |
NPD6190 |
Approved |
0.814 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.814 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8081 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8059 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7904 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7886 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7865 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7571 |
Intermediate Similarity |
NPD7240 |
Approved |
0.756 |
Intermediate Similarity |
NPD37 |
Approved |
0.7545 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7529 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7423 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7305 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7296 |
Intermediate Similarity |
NPD943 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5353 |
Approved |
0.724 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.724 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7158 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7119 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7102 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7091 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7052 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6782 |
Approved |
0.703 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD7698 |
Approved |
0.701 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.701 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD9494 |
Approved |
0.6977 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1613 |
Approved |
0.6973 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD5401 |
Approved |
0.6941 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD6385 |
Approved |
0.6897 |
Remote Similarity |
NPD6386 |
Approved |
0.6895 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6895 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6895 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6889 |
Remote Similarity |
NPD5242 |
Approved |
0.6878 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD5404 |
Approved |
0.6867 |
Remote Similarity |
NPD5406 |
Approved |
0.6867 |
Remote Similarity |
NPD5408 |
Approved |
0.6867 |
Remote Similarity |
NPD5405 |
Approved |
0.6867 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.685 |
Remote Similarity |
NPD7801 |
Approved |
0.6842 |
Remote Similarity |
NPD2532 |
Approved |
0.6842 |
Remote Similarity |
NPD2534 |
Approved |
0.6842 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2533 |
Approved |
0.6842 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6832 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD1933 |
Approved |
0.6784 |
Remote Similarity |
NPD7585 |
Approved |
0.6778 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6768 |
Remote Similarity |
NPD1240 |
Approved |
0.6766 |
Remote Similarity |
NPD2796 |
Approved |
0.6766 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6747 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6734 |
Remote Similarity |
NPD7583 |
Approved |
0.673 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD447 |
Suspended |
0.672 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD3748 |
Approved |
0.6706 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD1607 |
Approved |
0.6686 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.665 |
Remote Similarity |
NPD7584 |
Approved |
0.6647 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6631 |
Remote Similarity |
NPD7038 |
Approved |
0.6631 |
Remote Similarity |
NPD7039 |
Approved |
0.6612 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6608 |
Remote Similarity |
NPD7003 |
Approved |
0.6575 |
Remote Similarity |
NPD919 |
Approved |
0.6559 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.655 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6545 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6532 |
Remote Similarity |
NPD7440 |
Discontinued |
0.6524 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6519 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6517 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD6273 |
Approved |
0.6508 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6505 |
Remote Similarity |
NPD7799 |
Discontinued |
0.65 |
Remote Similarity |
NPD1091 |
Approved |
0.6497 |
Remote Similarity |
NPD3226 |
Approved |
0.6494 |
Remote Similarity |
NPD4357 |
Discontinued |
0.649 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6489 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6485 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD6099 |
Approved |
0.6471 |
Remote Similarity |
NPD6100 |
Approved |
0.6471 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6467 |
Remote Similarity |
NPD5711 |
Approved |
0.6467 |
Remote Similarity |
NPD5710 |
Approved |
0.6467 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6446 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD1203 |
Approved |
0.6436 |
Remote Similarity |
NPD7999 |
Approved |
0.6433 |
Remote Similarity |
NPD9493 |
Approved |
0.6432
|
Remote Similarity |
NPD8486 |
Clinical (unspecified phase) |